A phase 2, open-label, single-arm sulfasalazine monotherapy trial of progression-free survival in patients with pancreatic adenocarcinoma
ACTRN 12621001347853 Brief Summary This study will assess the anti-cancer activity of…
Read more arrow_forwardACTRN 12621001347853 Brief Summary This study will assess the anti-cancer activity of…
Read more arrow_forwardNCT 03165734 Brief Summary This study (study ID PAC203 North America; PAC303…
Read more arrow_forwardNCT 06879041 Brief Summary The main purpose of the study is to…
Read more arrow_forwardACTRN 12617001579381 Brief Summary The aim of this project is to evaluate…
Read more arrow_forwardACTRN 12622000675729 Brief Summary The aim of this study is to assess…
Read more arrow_forwardACTRN 12623000956606 Brief Summary This study will be conducted in two parts…
Read more arrow_forwardNCT 06384352 Brief Summary This is a multicenter, open-label, Phase 1 study.…
Read more arrow_forwardACTRN 12620000592943 Brief Summary This purpose of this study is to determine…
Read more arrow_forwardACTRN 12623000307606 Brief Summary This study is investigating a new cancer treatment…
Read more arrow_forwardACTRN 12622001339741 Brief Summary This is a first in human study of…
Read more arrow_forward